The healthcare-acquired infection is a new infection that develops in a patient during hospitalization.
This report aims to provide a comprehensive presentation of the global market for Healthcare-Acquired Infection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Healthcare-Acquired Infection. This report contains market size and forecasts of Healthcare-Acquired Infection in global, including the following market information:
Global Healthcare-Acquired Infection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Healthcare-Acquired Infection market was valued at US$ 24880 million in 2022 and is projected to reach US$ 40490 million by 2029, at a CAGR of 7.2% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Pharmaceutical Treatment Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Healthcare-Acquired Infection include Pfizer, Novartis, Roche, Sanofi, Abbott, BD and Hologic, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Healthcare-Acquired Infection companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Healthcare-Acquired Infection Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Type, 2022 (%)
Pharmaceutical Treatment
Environment Treatment
Medical Devices Management
Global Healthcare-Acquired Infection Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Healthcare-Acquired Infection Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Ambulatory Surgery Centers
Others
Global Healthcare-Acquired Infection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Healthcare-Acquired Infection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Healthcare-Acquired Infection revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Healthcare-Acquired Infection revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Novartis
Roche
Sanofi
Abbott
BD
Hologic
Outline of Major Chapters:
Chapter 1: Introduces the definition of Healthcare-Acquired Infection, market overview.
Chapter 2: Global Healthcare-Acquired Infection market size in revenue.
Chapter 3: Detailed analysis of Healthcare-Acquired Infection company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Healthcare-Acquired Infection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Healthcare-Acquired Infection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Healthcare-Acquired Infection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Healthcare-Acquired Infection Overall Market Size
2.1 Global Healthcare-Acquired Infection Market Size: 2022 VS 2029
2.2 Global Healthcare-Acquired Infection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Healthcare-Acquired Infection Players in Global Market
3.2 Top Global Healthcare-Acquired Infection Companies Ranked by Revenue
3.3 Global Healthcare-Acquired Infection Revenue by Companies
3.4 Top 3 and Top 5 Healthcare-Acquired Infection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Healthcare-Acquired Infection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Healthcare-Acquired Infection Players in Global Market
3.6.1 List of Global Tier 1 Healthcare-Acquired Infection Companies
3.6.2 List of Global Tier 2 and Tier 3 Healthcare-Acquired Infection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Healthcare-Acquired Infection Market Size Markets, 2022 & 2029
4.1.2 Pharmaceutical Treatment
4.1.3 Environment Treatment
4.1.4 Medical Devices Management
4.2 By Type - Global Healthcare-Acquired Infection Revenue & Forecasts
4.2.1 By Type - Global Healthcare-Acquired Infection Revenue, 2018-2023
4.2.2 By Type - Global Healthcare-Acquired Infection Revenue, 2024-2029
4.2.3 By Type - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Healthcare-Acquired Infection Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Ambulatory Surgery Centers
5.1.5 Others
5.2 By Application - Global Healthcare-Acquired Infection Revenue & Forecasts
5.2.1 By Application - Global Healthcare-Acquired Infection Revenue, 2018-2023
5.2.2 By Application - Global Healthcare-Acquired Infection Revenue, 2024-2029
5.2.3 By Application - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Healthcare-Acquired Infection Market Size, 2022 & 2029
6.2 By Region - Global Healthcare-Acquired Infection Revenue & Forecasts
6.2.1 By Region - Global Healthcare-Acquired Infection Revenue, 2018-2023
6.2.2 By Region - Global Healthcare-Acquired Infection Revenue, 2024-2029
6.2.3 By Region - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Healthcare-Acquired Infection Revenue, 2018-2029
6.3.2 US Healthcare-Acquired Infection Market Size, 2018-2029
6.3.3 Canada Healthcare-Acquired Infection Market Size, 2018-2029
6.3.4 Mexico Healthcare-Acquired Infection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Healthcare-Acquired Infection Revenue, 2018-2029
6.4.2 Germany Healthcare-Acquired Infection Market Size, 2018-2029
6.4.3 France Healthcare-Acquired Infection Market Size, 2018-2029
6.4.4 U.K. Healthcare-Acquired Infection Market Size, 2018-2029
6.4.5 Italy Healthcare-Acquired Infection Market Size, 2018-2029
6.4.6 Russia Healthcare-Acquired Infection Market Size, 2018-2029
6.4.7 Nordic Countries Healthcare-Acquired Infection Market Size, 2018-2029
6.4.8 Benelux Healthcare-Acquired Infection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Healthcare-Acquired Infection Revenue, 2018-2029
6.5.2 China Healthcare-Acquired Infection Market Size, 2018-2029
6.5.3 Japan Healthcare-Acquired Infection Market Size, 2018-2029
6.5.4 South Korea Healthcare-Acquired Infection Market Size, 2018-2029
6.5.5 Southeast Asia Healthcare-Acquired Infection Market Size, 2018-2029
6.5.6 India Healthcare-Acquired Infection Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Healthcare-Acquired Infection Revenue, 2018-2029
6.6.2 Brazil Healthcare-Acquired Infection Market Size, 2018-2029
6.6.3 Argentina Healthcare-Acquired Infection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, 2018-2029
6.7.2 Turkey Healthcare-Acquired Infection Market Size, 2018-2029
6.7.3 Israel Healthcare-Acquired Infection Market Size, 2018-2029
6.7.4 Saudi Arabia Healthcare-Acquired Infection Market Size, 2018-2029
6.7.5 UAE Healthcare-Acquired Infection Market Size, 2018-2029
7 Healthcare-Acquired Infection Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Healthcare-Acquired Infection Major Product Offerings
7.1.4 Pfizer Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis Healthcare-Acquired Infection Major Product Offerings
7.2.4 Novartis Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Healthcare-Acquired Infection Major Product Offerings
7.3.4 Roche Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Healthcare-Acquired Infection Major Product Offerings
7.4.4 Sanofi Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Abbott
7.5.1 Abbott Company Summary
7.5.2 Abbott Business Overview
7.5.3 Abbott Healthcare-Acquired Infection Major Product Offerings
7.5.4 Abbott Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.5.5 Abbott Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Healthcare-Acquired Infection Major Product Offerings
7.6.4 BD Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Hologic
7.7.1 Hologic Company Summary
7.7.2 Hologic Business Overview
7.7.3 Hologic Healthcare-Acquired Infection Major Product Offerings
7.7.4 Hologic Healthcare-Acquired Infection Revenue in Global Market (2018-2023)
7.7.5 Hologic Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Healthcare-Acquired Infection Market Opportunities & Trends in Global Market
Table 2. Healthcare-Acquired Infection Market Drivers in Global Market
Table 3. Healthcare-Acquired Infection Market Restraints in Global Market
Table 4. Key Players of Healthcare-Acquired Infection in Global Market
Table 5. Top Healthcare-Acquired Infection Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Healthcare-Acquired Infection Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Healthcare-Acquired Infection Revenue Share by Companies, 2018-2023
Table 8. Global Companies Healthcare-Acquired Infection Product Type
Table 9. List of Global Tier 1 Healthcare-Acquired Infection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Healthcare-Acquired Infection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Healthcare-Acquired Infection Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Healthcare-Acquired Infection Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Healthcare-Acquired Infection Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Healthcare-Acquired Infection Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Healthcare-Acquired Infection Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Healthcare-Acquired Infection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue, (US$, Mn), 2024-2029
Table 30. Pfizer Company Summary
Table 31. Pfizer Healthcare-Acquired Infection Product Offerings
Table 32. Pfizer Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 33. Pfizer Key News & Latest Developments
Table 34. Novartis Company Summary
Table 35. Novartis Healthcare-Acquired Infection Product Offerings
Table 36. Novartis Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis Key News & Latest Developments
Table 38. Roche Company Summary
Table 39. Roche Healthcare-Acquired Infection Product Offerings
Table 40. Roche Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 41. Roche Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Healthcare-Acquired Infection Product Offerings
Table 44. Sanofi Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Abbott Company Summary
Table 47. Abbott Healthcare-Acquired Infection Product Offerings
Table 48. Abbott Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. BD Company Summary
Table 51. BD Healthcare-Acquired Infection Product Offerings
Table 52. BD Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 53. BD Key News & Latest Developments
Table 54. Hologic Company Summary
Table 55. Hologic Healthcare-Acquired Infection Product Offerings
Table 56. Hologic Healthcare-Acquired Infection Revenue (US$, Mn) & (2018-2023)
Table 57. Hologic Key News & Latest Developments
List of Figures
Figure 1. Healthcare-Acquired Infection Segment by Type in 2022
Figure 2. Healthcare-Acquired Infection Segment by Application in 2022
Figure 3. Global Healthcare-Acquired Infection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Healthcare-Acquired Infection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Healthcare-Acquired Infection Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Healthcare-Acquired Infection Revenue in 2022
Figure 8. By Type - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 9. By Application - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 10. By Type - Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 12. By Application - Global Healthcare-Acquired Infection Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 14. By Region - Global Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 15. By Country - North America Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 16. US Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 20. Germany Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 21. France Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 28. China Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 32. India Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 34. Brazil Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Healthcare-Acquired Infection Revenue Market Share, 2018-2029
Figure 37. Turkey Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Healthcare-Acquired Infection Revenue, (US$, Mn), 2018-2029
Figure 41. Pfizer Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Roche Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Abbott Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BD Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Hologic Healthcare-Acquired Infection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
